University of Guelph-affiliated company to provide WeedMD with innovative tissue cultured-plant services via Steadystem Solutions for cloning accuracy and plant asset preservation...
WeedMD announced today its financial results for the three months ended March 31, 2020....
Company’s products on ‘Medical Cannabis by Shoppers’ platform, registered under blockchain-enabled program added to University Health Network’s research trials...
Amendments to the terms of the Company’s $39 million senior secured credit facility provide WeedMD with greater financial flexibility ...
Sequential 325% quarter-over-quarter growth signals strong demand and brand recognition...
Strain-specific ‘Aurum’ vapes produced in-house at Company’s CX Industries’ facility expands Company’s medical product portfolio...
Pilot project ‘PatientDirect’ kicks off in June with express delivery to Toronto-area patients...
Kicks-off second-year outdoors with over 18,000 plants slated for fall harvest, confirms 2019 outdoor biomass now in extraction for new cannabis formats at CX Industries...
WeedMD announced today its financial results for the fiscal year ended December 31, 2019, including a 162% net revenue increase to $20.8 million, compared with $8.0 million for the prior year....
WeedMD announced today that it will file its financial statements for the first quarter ended March 31, 2020 on or before July 15, 2020....
To help ensure our patients are up to date with all procedures and measures being taken during this time, we have created a website specific to WeedMD and COVID-19 updates.
VISIT PAGE NOW
X
Our patients will soon have access to a diverse new medical cannabis offering, featuring familiar WeedMD products as well as new strains, formats and services. This includes access to vapes, same day shipping, a Client Care Team available 7 days a week, and lots more.
Get started below or view our FAQ to learn more about our new one world of medical cannabis services.
Let’s Get Started